We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novozymes Biopharma to Unveil New Research into the Production of Proteins with Extended Circulatory Half-life at Next Generation Protein Therapeutics Summit

Product News   Jun 08, 2011

 
Novozymes Biopharma to Unveil New Research into the Production of Proteins with Extended Circulatory Half-life at Next Generation Protein Therapeutics Summit
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Lonza Launches New Media and Feeds to Support Recombinant Protein Production Scale-Up

Product News

Lonza has expanded its cell culture media portfolio with the addition of the GSv9™ Media and Feeds, providing a fully integrated solution specifically designed to optimize recombinant protein production using Lonza’s GS Gene Expression System®.

READ MORE

Avacta Provides Update on Affimer Therapy for COVID-19 Infection

Product News

Infectivity assays have shown that Affimer reagents can prevent infection of human cells by a SARS-CoV-2 model virus.

READ MORE

Screening for Novel Inhibitors of SARS-CoV-2

Product News

AMSBIO has reported on the pioneering work by researchers at the University of Sheffield, UK to measure the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain and heparin.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE